Search results
14 Nov 2022 · SINGAPORE – BioNTech on Monday confirmed that its first mRNA manufacturing plant in Singapore will be operational in late 2023, with the facility also serving as the German company’s regional...
10 Mei 2021 · SINGAPORE - BioNTech, the vaccine maker that has partnered with Pfizer on its Covid-19 shot, will be designating Singapore as its regional headquarters for South-east Asia, and will set up an...
13 Nov 2022 · The acquisition is part of BioNTech’s expansion strategy to strengthen its global footprint in Asia. Supported by the Singapore Economic Development Board (“EDB”), the facility will serve as BioNTech’s Regional Headquarters and become its first mRNA manufacturing facility in Singapore.
10 Mei 2021 · SINGAPORE — BioNTech announced Monday it will set up its Southeast Asia headquarters in Singapore, and will build a manufacturing facility in the city-state to produce its messenger RNA...
Locations. From our roots in Mainz we have grown into a global immunotherapy powerhouse. Fully integrated with a strong focus on R&D. We want to establish a new era of immunotherapies and develop innovative approaches against cancer, infectious and other serious diseases.
11 Mei 2021 · BioNTech SE, the vaccine-maker that partnered Pfizer to produce the widely used Covid-19 shot, will be designating Singapore as its regional headquarters for South-east Asia. It also plans to...
14 Nov 2022 · BioNTech’s Singapore mRNA manufacturing facility will create regional manufacturing capacities in support of BioNTech’s growing pipeline of mRNA-based vaccines and therapeutics across Asia...
